CD5 and neoplasm: Furthermore, the IL-7R-IM strategy successfully enhanced the function of CAR-NK cells targeting EphA2, EGFR, and CD5 antigens.<h4>Conclusions</h4>The expression of IL-7R-IM confers cytokine independence and robust anti-tumor activity to NK and CAR-NK cells.